Sangamo Therapeutics
SGMO
SGMO
131 hedge funds and large institutions have $68.2M invested in Sangamo Therapeutics in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 30 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
131
Holders Change
+1
Holders Change %
+0.77%
% of All Funds
1.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
30
Reduced
50
Closed
17
Calls
$95K
Puts
$170K
Net Calls
-$75K
Net Calls Change
-$48K
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
$11.4M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
$13.5M |
| 3 |
Mirae Asset Global Investments
Seoul,
South Korea
|
$839K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
$298K |
| 5 |
Goldman Sachs
New York
|
$424K |
Top Sellers
| 1 |
Two Sigma Investments
New York
|
$372K |
| 2 |
D.E. Shaw & Co
New York
|
$2.06M |
| 3 |
Morgan Stanley
New York
|
$358K |
| 4 |
Citadel Advisors
Miami,
Florida
|
$34.8K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
$921K |
